A rapid neutralization test for influenza A and B viruses was developed. In this method, a 96-well tissue culture plate was used for the preparation of cell monolayers and the peroxidase-antiperoxidase staining technique was used for the visualization of foci infected with these viruses. In the presence of trypsin and tragacanth gum, clear foci developed 1 day after infection. A linear relationship between virus dilutions and numbers of foci was observed. When neutralizing antibodies in some test sera were assayed, a good correlation was observed between the titers obtained by the focus method and those obtained by the ordinary plaque method. In addition, many serum specimens were investigated by the neutralization test, and it was demonstrated that the test is useful for serological studies of influenza.
Although the hemagglutination inhibition (HI) test is the most commonly used technique for the measurement of antibody to influenza virus, the neutralization test is superior to the HI test in that it is more specific and usually more sensitive than the HI test (6, 7, 22) . Moreover, dissociation of the neutralizing effect and antihemagglutination activity in polyclonal sera (10, 21) or monoclonal antibodies (4, 9) have been reported. Despite the importance of the neutralization test in serological studies of influenza, the test has rarely been used because it is too cumbersome, time-consuming, and expensive. Trials of a microneutralization test that uses microplates (3, 20) have been reported. However, this method requires a long incubation period of approximately 1 week after virus infection. Recently, Harmon et al. (7) reported a rapid neutralizing-antibody assay for influenza B viruses based on an enzyme immunoassay. We tried to develop a rapid neutralization test in a microtiter system for influenza A and B viruses. This paper describes the usefulness of the microneutralization test in serological studies of influenza.
MATERIALS AND METHODS
Virus strains. Six strains of influenza A and B viruses were used. Four of them, A/Yamagata/120/86 (HlNi), A/Fukuoka/C29/85 (H3N2), A/Shisen/2/87 (H3N2), and B/Nagasaki/ 1/87, which are inactivated-vaccine strains currently in use in Japan, were generously provided by the Research Foundation for Microbial Diseases of Osaka University. Two others, A/Okuda/57 (H2N2) and B/Osaka/152/88, have been kept in our laboratory. A/Okuda/57 (H2N2) was passaged more than 200 times in chorioallantoic membranes of embryonated hen eggs. B/Osaka/152/88 was isolated from patients with influenza by use of Madin-Darby canine kidney (MDCK) cells and passaged several times in the eggs. These * Corresponding author.
egg-passaged viruses were propagated one more time and stored at -70°C for this study.
Cell culture. MDCK cells were maintained at 37°C in a 5% C02 atmosphere in Eagle minimal essential medium (MEM) supplemented with 10% fetal bovine serum, penicillin (100 U/ml), and streptomycin (100 U/ml).
Human sera. Sixty serum samples were obtained from students of an elementary school in Osaka City. They were heat inactivated at 56°C for 30 min before use.
HI test. The HI test was performed with receptor-destroying enzyme-treated sera by a standard microtiter assay (1) . In the test, ether-treated egg-derived virus antigens which had been prepared at the Kanonji Institute of the Research Foundation for Microbial Diseases of Osaka University were used.
Focus reduction neutralization test. In principle, the newly developed neutralization test for influenza A and B viruses was based on our previously described methods (12, 15 10 ,ktg/ml, clear foci were made and no differences in the focus number or focus size were observed. Therefore, in the present study, 5 ,ug of trypsin per ml was added to the medium. Tragacanth gum was used to localize the foci. The appropriate concentration of the gum in the medium was 0.5%. In the case of the influenza B viruses, clear foci were formed regardless of the existence of trypsin and the gum in the medium.
The appropriate incubation period for focus counting was 20 Although A/Okuda/57 (H2N2) had almost the same titers in the two methods, A/Yamagatall20/86 (HlNi) and B/Nagasaki/l/87 had higher titers in the plaque method than in the focus method. The plaques produced by A/Fukuoka/C29/85 (H3N2) were too small and obscure for counting. To evaluate the focus method for the titration of neutralizing antibodies, we studied serum specimens from six elementary-school students by the plaque and focus reduction methods and by the method of Frank et al. (3) with three strains of influenza virus ( Table 2 ). The difference in the neutralizing-antibody titers measured by the three methods was small, at most a fourfold difference. The results indicate that the ordinary plaque method and the method of Frank et al. can be replaced by the focus method in the neutralization test for influenza A and B viruses.
Application of the micromethod for serological investigations. Sixty serum specimens were collected from students of an elementary school in Osaka City and titrated against influenza A and B viruses by the HI and neutralization tests. Figure 3 shows the relationship between HI and neutralizingantibody titers against three strains of influenza A virus.
There was a good agreement between the HI and neutralizing-antibody titers against A/Yamagatall20/86 (HlNi) (Fig.  3A) and A/Fukuoka/C29/85 (H3N2) (Fig. 3B) . However, when they were measured against A/Shisen/2/87 (H3N2) (Fig. 3C) Figure 4 shows the relationship between HI and neutralizing-antibody titers against two strains of influenza B virus. The neutralizing-antibody titers were slightly higher than the HI titers against B/Nagasaki/1/87 (Fig. 4A) (2, 8, 12, 13, 15, 17) and demonstrated that the tests were useful for serological studies of these viruses (11, 16, 19) . In this study, we developed a microtitration system for influenza A and B viruses based on the method described above (12, 15) and applied the system to a neutralization test for influenza.
In the newly developed neutralization test, residual virus infectivity was obtained by counting foci stained by the PAP technique. The fundamental difference between our focus method and the conventional plaque method is that the former method does not require cell destruction or damage by the virus infection which, however, is essential for the latter method. Therefore, results can be obtained faster by the focus method (1 day after infection) than by the plaque method (more than 3 days after infection). Moreover, the focus method can be applied to viruses such as A/Fukuoka/ C29/85 (H3N2) that have difficulty in producing cytopathic effects or plaques (Table 1 ). In addition, the focus method has several other advantages over the plaque method. Since the focus method is a micromethod, it requires small amounts of test serum, cells, and medium and little incubator space. Stained foci in the plate can be kept for a long time and can be counted any time. Because 96-well tissue culture plates are used for both cell cultivation and serum dilution, the neutralization test can be carried out systematically in a short time with a multichannel pipette.
In the present study, we used the PAP technique to visualize infected cells because it had been shown to be the most suitable technique in terms of background staining and sensitivity when three immunoperoxidase techniques (direct, indirect, and PAP) were compared (14) . (Fig. 1 ). Although differences in focus sizes among these strains were observed, the focus numbers could be counted quantitatively (Fig. 2) .
For A/Yamagata/120/86 and B/Nagasaki/1/87, infectivity titers measured by the plaque method were not consistent with those measured by the focus method (Table 1) . Moreover, large differences between the sensitivities of virus detection by the method of Frank et al. (3) and the other two methods were observed (data not shown). However, there was good agreement among the neutralizing-antibody titers obtained by the three methods (Table 2 ). These results indicate that different sensitivities among the three methods in detecting virus multiplication did not affect the neutralizing-antibody titers, since they were determined on the basis of control values.
The serum antibodies in the students were measured by the neutralization and HI tests (Fig. 3 and 4) . When they were titrated against the vaccine strains (A/Yamagata/120/ 86, A/Fukuoka/C29/85, and B/Nagasaki/l/87), differences between the neutralization and HI titers were small. However, when they were titrated against the new strain, A/ Shisen/2/87, with which the students had not been vaccinated, or the recent epidemic strain, B/Osaka/152/88, the differences were large. The possibility that noninfectious virus particles consume neutralizing antibodies and thus result in lower actual titers, as suspected in the neutralization tests with A/Shisen/2/87, seems unlikely because the ratio between infectivity and the hemagglutinin titer of A/Shisen/2/87 was not lower than that of other strains. Therefore, these observations seem to indicate that the neutralization test is more specific than the HI test.
When we measured serum antibodies in some adults, positive titers could be detected by the neutralization test but not by the HI test (unpublished results). Other investigators also showed that neutralization tests were more sensitive and useful than HI tests, especially when they were used for the detection of low titers (6, 7, 22) . Therefore, the neutralization test seems to have advantages when antibody levels are low, with negligible or negative titers in the HI test.
The usefulness of the microneutralization test was also demonstrated in a recent study in which neutralizing antibodies in nasal wash specimens in children were measured (data not shown). Since local secretory neutralizing antibodies work directly to protect against infection from influenza, an assay of the antibodies is important. Therefore, the neutralization test which we developed can potentially be widely used for antibody titration not only in sera but also in nasal wash specimens.
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